Lung Cancer Diagnostic Tests Market Report

Japan Lung Cancer Diagnostic Tests Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • POSTDATE：Jun 21, 2020
  • PAGES：219
  • REPORT CODE：GMM572758
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Growing prevalence of oncologic cases, constant technological advancements in diagnostics, and increasing demand for effective screening tests are some of the prime factors spurring demand for screening tools and techniques across the world. Rising awareness and supportive government initiatives are some additional factors anticipated to boost market growth during the forecast period.

    This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Lung Cancer Diagnostic Tests market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Lung Cancer Diagnostic Tests market. Detailed analysis of key players, along with key growth strategies adopted by Lung Cancer Diagnostic Tests industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Advpharma Inc

    • Quest Diagnostics Austrian Institute of Technology GmbH

    • Agilent

    • Mayo Clinic LLC

    • Emory University

    • Biodesix

    • HalioDx

    • Courtagen Life Sciences Inc SAS

    • Epigenomics AG US

    By Type:

    • Immunoassays

    • Flow Cytometry

    • Rapid Tests

    • Molecular Assays

    • Tissue Arrays

    • Circulating Tumor Cells

    • Pharmacodiagnostics

    • Biomarkers

    • Other Diagnostics Methods

    By End-User:

    • Precision Medicine

    • Personalized Medicine

    • Cancer Monitoring

    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Lung Cancer Diagnostic Tests Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Lung Cancer Diagnostic Tests Market Size and Growth Rate of Immunoassays from 2014 to 2026

      • 1.3.2 Japan Lung Cancer Diagnostic Tests Market Size and Growth Rate of Flow Cytometry from 2014 to 2026

      • 1.3.3 Japan Lung Cancer Diagnostic Tests Market Size and Growth Rate of Rapid Tests from 2014 to 2026

      • 1.3.4 Japan Lung Cancer Diagnostic Tests Market Size and Growth Rate of Molecular Assays from 2014 to 2026

      • 1.3.5 Japan Lung Cancer Diagnostic Tests Market Size and Growth Rate of Tissue Arrays from 2014 to 2026

      • 1.3.6 Japan Lung Cancer Diagnostic Tests Market Size and Growth Rate of Circulating Tumor Cells from 2014 to 2026

      • 1.3.7 Japan Lung Cancer Diagnostic Tests Market Size and Growth Rate of Pharmacodiagnostics from 2014 to 2026

      • 1.3.8 Japan Lung Cancer Diagnostic Tests Market Size and Growth Rate of Biomarkers from 2014 to 2026

      • 1.3.9 Japan Lung Cancer Diagnostic Tests Market Size and Growth Rate of Other Diagnostics Methods from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Market Size and Growth Rate of Precision Medicine

      • 1.4.2 Market Size and Growth Rate of Personalized Medicine

      • 1.4.3 Market Size and Growth Rate of Cancer Monitoring

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Lung Cancer Diagnostic Tests Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Lung Cancer Diagnostic Tests by Major Types

      • 3.4.1 Japan Lung Cancer Diagnostic Tests Market Size and Growth Rate of Immunoassays from 2014 to 2026

      • 3.4.2 Japan Lung Cancer Diagnostic Tests Market Size and Growth Rate of Flow Cytometry from 2014 to 2026

      • 3.4.3 Japan Lung Cancer Diagnostic Tests Market Size and Growth Rate of Rapid Tests from 2014 to 2026

      • 3.4.4 Japan Lung Cancer Diagnostic Tests Market Size and Growth Rate of Molecular Assays from 2014 to 2026

      • 3.4.5 Japan Lung Cancer Diagnostic Tests Market Size and Growth Rate of Tissue Arrays from 2014 to 2026

      • 3.4.6 Japan Lung Cancer Diagnostic Tests Market Size and Growth Rate of Circulating Tumor Cells from 2014 to 2026

      • 3.4.7 Japan Lung Cancer Diagnostic Tests Market Size and Growth Rate of Pharmacodiagnostics from 2014 to 2026

      • 3.4.8 Japan Lung Cancer Diagnostic Tests Market Size and Growth Rate of Biomarkers from 2014 to 2026

      • 3.4.9 Japan Lung Cancer Diagnostic Tests Market Size and Growth Rate of Other Diagnostics Methods from 2014 to 2026

    4 Segmentation of Lung Cancer Diagnostic Tests Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Lung Cancer Diagnostic Tests by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Lung Cancer Diagnostic Tests in Precision Medicine

      • 4.4.2 Market Size and Growth Rate of Lung Cancer Diagnostic Tests in Personalized Medicine

      • 4.4.3 Market Size and Growth Rate of Lung Cancer Diagnostic Tests in Cancer Monitoring

    5 Market Analysis by Regions

    • 5.1 Japan Lung Cancer Diagnostic Tests Production Analysis by Regions

    • 5.2 Japan Lung Cancer Diagnostic Tests Consumption Analysis by Regions

    6 Hokkaido Lung Cancer Diagnostic Tests Landscape Analysis

    • 6.1 Hokkaido Lung Cancer Diagnostic Tests Landscape Analysis by Major Types

    • 6.2 Hokkaido Lung Cancer Diagnostic Tests Landscape Analysis by Major End-Users

    7 Tohoku Lung Cancer Diagnostic Tests Landscape Analysis

    • 7.1 Tohoku Lung Cancer Diagnostic Tests Landscape Analysis by Major Types

    • 7.2 Tohoku Lung Cancer Diagnostic Tests Landscape Analysis by Major End-Users

    8 Kanto Lung Cancer Diagnostic Tests Landscape Analysis

    • 8.1 Kanto Lung Cancer Diagnostic Tests Landscape Analysis by Major Types

    • 8.2 Kanto Lung Cancer Diagnostic Tests Landscape Analysis by Major End-Users

    9 Chubu Lung Cancer Diagnostic Tests Landscape Analysis

    • 9.1 Chubu Lung Cancer Diagnostic Tests Landscape Analysis by Major Types

    • 9.2 Chubu Lung Cancer Diagnostic Tests Landscape Analysis by Major End-Users

    10 Kinki Lung Cancer Diagnostic Tests Landscape Analysis

    • 10.1 Kinki Lung Cancer Diagnostic Tests Landscape Analysis by Major Types

    • 10.2 Kinki Lung Cancer Diagnostic Tests Landscape Analysis by Major End-Users

    11 Chugoku Lung Cancer Diagnostic Tests Landscape Analysis

    • 11.1 Chugoku Lung Cancer Diagnostic Tests Landscape Analysis by Major Types

    • 11.2 Chugoku Lung Cancer Diagnostic Tests Landscape Analysis by Major End-Users

    12 Shikoku Lung Cancer Diagnostic Tests Landscape Analysis

    • 12.1 Shikoku Lung Cancer Diagnostic Tests Landscape Analysis by Major Types

    • 12.2 Shikoku Lung Cancer Diagnostic Tests Landscape Analysis by Major End-Users

    13 Kyushu Lung Cancer Diagnostic Tests Landscape Analysis

    • 13.1 Kyushu Lung Cancer Diagnostic Tests Landscape Analysis by Major Types

    • 13.2 Kyushu Lung Cancer Diagnostic Tests Landscape Analysis by Major End-Users

    14 Major Players Profiles

    • 14.1 Advpharma Inc

      • 14.1.1 Advpharma Inc Company Profile and Recent Development

      • 14.1.2 Advpharma Inc Market Performance

      • 14.1.3 Advpharma Inc Product and Service Introduction

    • 14.2 Quest Diagnostics Austrian Institute of Technology GmbH

      • 14.2.1 Quest Diagnostics Austrian Institute of Technology GmbH Company Profile and Recent Development

      • 14.2.2 Quest Diagnostics Austrian Institute of Technology GmbH Market Performance

      • 14.2.3 Quest Diagnostics Austrian Institute of Technology GmbH Product and Service Introduction

    • 14.3 Agilent

      • 14.3.1 Agilent Company Profile and Recent Development

      • 14.3.2 Agilent Market Performance

      • 14.3.3 Agilent Product and Service Introduction

    • 14.4 Mayo Clinic LLC

      • 14.4.1 Mayo Clinic LLC Company Profile and Recent Development

      • 14.4.2 Mayo Clinic LLC Market Performance

      • 14.4.3 Mayo Clinic LLC Product and Service Introduction

    • 14.5 Emory University

      • 14.5.1 Emory University Company Profile and Recent Development

      • 14.5.2 Emory University Market Performance

      • 14.5.3 Emory University Product and Service Introduction

    • 14.6 Biodesix

      • 14.6.1 Biodesix Company Profile and Recent Development

      • 14.6.2 Biodesix Market Performance

      • 14.6.3 Biodesix Product and Service Introduction

    • 14.7 HalioDx

      • 14.7.1 HalioDx Company Profile and Recent Development

      • 14.7.2 HalioDx Market Performance

      • 14.7.3 HalioDx Product and Service Introduction

    • 14.8 Courtagen Life Sciences Inc SAS

      • 14.8.1 Courtagen Life Sciences Inc SAS Company Profile and Recent Development

      • 14.8.2 Courtagen Life Sciences Inc SAS Market Performance

      • 14.8.3 Courtagen Life Sciences Inc SAS Product and Service Introduction

    • 14.9 Epigenomics AG US

      • 14.9.1 Epigenomics AG US Company Profile and Recent Development

      • 14.9.2 Epigenomics AG US Market Performance

      • 14.9.3 Epigenomics AG US Product and Service Introduction

     

    The List of Tables and Figures (Totals 111 Figures and 197 Tables)

    • Figure Japan Lung Cancer Diagnostic Tests Market Size and Growth Rate of Immunoassays from 2014 to 2026

    • Figure Japan Lung Cancer Diagnostic Tests Market Size and Growth Rate of Flow Cytometry from 2014 to 2026

    • Figure Japan Lung Cancer Diagnostic Tests Market Size and Growth Rate of Rapid Tests from 2014 to 2026

    • Figure Japan Lung Cancer Diagnostic Tests Market Size and Growth Rate of Molecular Assays from 2014 to 2026

    • Figure Japan Lung Cancer Diagnostic Tests Market Size and Growth Rate of Tissue Arrays from 2014 to 2026

    • Figure Japan Lung Cancer Diagnostic Tests Market Size and Growth Rate of Circulating Tumor Cells from 2014 to 2026

    • Figure Japan Lung Cancer Diagnostic Tests Market Size and Growth Rate of Pharmacodiagnostics from 2014 to 2026

    • Figure Japan Lung Cancer Diagnostic Tests Market Size and Growth Rate of Biomarkers from 2014 to 2026

    • Figure Japan Lung Cancer Diagnostic Tests Market Size and Growth Rate of Other Diagnostics Methods from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Market Size and Growth Rate of Precision Medicine

    • Figure Market Size and Growth Rate of Personalized Medicine

    • Figure Market Size and Growth Rate of Cancer Monitoring

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Lung Cancer Diagnostic Tests Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Lung Cancer Diagnostic Tests

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Lung Cancer Diagnostic Tests by Different Types from 2014 to 2026

    • Table Consumption Share of Lung Cancer Diagnostic Tests by Different Types from 2014 to 2026

    • Figure Japan Lung Cancer Diagnostic Tests Market Size and Growth Rate of Immunoassays from 2014 to 2026

    • Figure Japan Lung Cancer Diagnostic Tests Market Size and Growth Rate of Flow Cytometry from 2014 to 2026

    • Figure Japan Lung Cancer Diagnostic Tests Market Size and Growth Rate of Rapid Tests from 2014 to 2026

    • Figure Japan Lung Cancer Diagnostic Tests Market Size and Growth Rate of Molecular Assays from 2014 to 2026

    • Figure Japan Lung Cancer Diagnostic Tests Market Size and Growth Rate of Tissue Arrays from 2014 to 2026

    • Figure Japan Lung Cancer Diagnostic Tests Market Size and Growth Rate of Circulating Tumor Cells from 2014 to 2026

    • Figure Japan Lung Cancer Diagnostic Tests Market Size and Growth Rate of Pharmacodiagnostics from 2014 to 2026

    • Figure Japan Lung Cancer Diagnostic Tests Market Size and Growth Rate of Biomarkers from 2014 to 2026

    • Figure Japan Lung Cancer Diagnostic Tests Market Size and Growth Rate of Other Diagnostics Methods from 2014 to 2026

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Lung Cancer Diagnostic Tests by Different End-Users from 2014 to 2026

    • Table Consumption Share of Lung Cancer Diagnostic Tests by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Precision Medicine

    • Figure Market Size and Growth Rate of Personalized Medicine

    • Figure Market Size and Growth Rate of Cancer Monitoring

    • Table Japan Lung Cancer Diagnostic Tests Production by Regions

    • Table Japan Lung Cancer Diagnostic Tests Production Share by Regions

    • Figure Japan Lung Cancer Diagnostic Tests Production Share by Regions in 2014

    • Figure Japan Lung Cancer Diagnostic Tests Production Share by Regions in 2018

    • Figure Japan Lung Cancer Diagnostic Tests Production Share by Regions in 2026

    • Table Japan Lung Cancer Diagnostic Tests Consumption by Regions

    • Table Japan Lung Cancer Diagnostic Tests Consumption Share by Regions

    • Figure Japan Lung Cancer Diagnostic Tests Consumption Share by Regions in 2014

    • Figure Japan Lung Cancer Diagnostic Tests Consumption Share by Regions in 2018

    • Figure Japan Lung Cancer Diagnostic Tests Consumption Share by Regions in 2026

    • Table Hokkaido Lung Cancer Diagnostic Tests Consumption by Types from 2014 to 2026

    • Table Hokkaido Lung Cancer Diagnostic Tests Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Lung Cancer Diagnostic Tests Consumption Share by Types in 2014

    • Figure Hokkaido Lung Cancer Diagnostic Tests Consumption Share by Types in 2018

    • Figure Hokkaido Lung Cancer Diagnostic Tests Consumption Share by Types in 2026

    • Table Hokkaido Lung Cancer Diagnostic Tests Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Lung Cancer Diagnostic Tests Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2014

    • Figure Hokkaido Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2018

    • Figure Hokkaido Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2026

    • Table Tohoku Lung Cancer Diagnostic Tests Consumption by Types from 2014 to 2026

    • Table Tohoku Lung Cancer Diagnostic Tests Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Lung Cancer Diagnostic Tests Consumption Share by Types in 2014

    • Figure Tohoku Lung Cancer Diagnostic Tests Consumption Share by Types in 2018

    • Figure Tohoku Lung Cancer Diagnostic Tests Consumption Share by Types in 2026

    • Table Tohoku Lung Cancer Diagnostic Tests Consumption by End-Users from 2014 to 2026

    • Table Tohoku Lung Cancer Diagnostic Tests Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2014

    • Figure Tohoku Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2018

    • Figure Tohoku Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2026

    • Table Kanto Lung Cancer Diagnostic Tests Consumption by Types from 2014 to 2026

    • Table Kanto Lung Cancer Diagnostic Tests Consumption Share by Types from 2014 to 2026

    • Figure Kanto Lung Cancer Diagnostic Tests Consumption Share by Types in 2014

    • Figure Kanto Lung Cancer Diagnostic Tests Consumption Share by Types in 2018

    • Figure Kanto Lung Cancer Diagnostic Tests Consumption Share by Types in 2026

    • Table Kanto Lung Cancer Diagnostic Tests Consumption by End-Users from 2014 to 2026

    • Table Kanto Lung Cancer Diagnostic Tests Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2014

    • Figure Kanto Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2018

    • Figure Kanto Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2026

    • Table Chubu Lung Cancer Diagnostic Tests Consumption by Types from 2014 to 2026

    • Table Chubu Lung Cancer Diagnostic Tests Consumption Share by Types from 2014 to 2026

    • Figure Chubu Lung Cancer Diagnostic Tests Consumption Share by Types in 2014

    • Figure Chubu Lung Cancer Diagnostic Tests Consumption Share by Types in 2018

    • Figure Chubu Lung Cancer Diagnostic Tests Consumption Share by Types in 2026

    • Table Chubu Lung Cancer Diagnostic Tests Consumption by End-Users from 2014 to 2026

    • Table Chubu Lung Cancer Diagnostic Tests Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2014

    • Figure Chubu Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2018

    • Figure Chubu Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2026

    • Table Kinki Lung Cancer Diagnostic Tests Consumption by Types from 2014 to 2026

    • Table Kinki Lung Cancer Diagnostic Tests Consumption Share by Types from 2014 to 2026

    • Figure Kinki Lung Cancer Diagnostic Tests Consumption Share by Types in 2014

    • Figure Kinki Lung Cancer Diagnostic Tests Consumption Share by Types in 2018

    • Figure Kinki Lung Cancer Diagnostic Tests Consumption Share by Types in 2026

    • Table Kinki Lung Cancer Diagnostic Tests Consumption by End-Users from 2014 to 2026

    • Table Kinki Lung Cancer Diagnostic Tests Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2014

    • Figure Kinki Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2018

    • Figure Kinki Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2026

    • Table Chugoku Lung Cancer Diagnostic Tests Consumption by Types from 2014 to 2026

    • Table Chugoku Lung Cancer Diagnostic Tests Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Lung Cancer Diagnostic Tests Consumption Share by Types in 2014

    • Figure Chugoku Lung Cancer Diagnostic Tests Consumption Share by Types in 2018

    • Figure Chugoku Lung Cancer Diagnostic Tests Consumption Share by Types in 2026

    • Table Chugoku Lung Cancer Diagnostic Tests Consumption by End-Users from 2014 to 2026

    • Table Chugoku Lung Cancer Diagnostic Tests Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2014

    • Figure Chugoku Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2018

    • Figure Chugoku Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2026

    • Table Shikoku Lung Cancer Diagnostic Tests Consumption by Types from 2014 to 2026

    • Table Shikoku Lung Cancer Diagnostic Tests Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Lung Cancer Diagnostic Tests Consumption Share by Types in 2014

    • Figure Shikoku Lung Cancer Diagnostic Tests Consumption Share by Types in 2018

    • Figure Shikoku Lung Cancer Diagnostic Tests Consumption Share by Types in 2026

    • Table Shikoku Lung Cancer Diagnostic Tests Consumption by End-Users from 2014 to 2026

    • Table Shikoku Lung Cancer Diagnostic Tests Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2014

    • Figure Shikoku Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2018

    • Figure Shikoku Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2026

    • Table Kyushu Lung Cancer Diagnostic Tests Consumption by Types from 2014 to 2026

    • Table Kyushu Lung Cancer Diagnostic Tests Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Lung Cancer Diagnostic Tests Consumption Share by Types in 2014

    • Figure Kyushu Lung Cancer Diagnostic Tests Consumption Share by Types in 2018

    • Figure Kyushu Lung Cancer Diagnostic Tests Consumption Share by Types in 2026

    • Table Kyushu Lung Cancer Diagnostic Tests Consumption by End-Users from 2014 to 2026

    • Table Kyushu Lung Cancer Diagnostic Tests Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2014

    • Figure Kyushu Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2018

    • Figure Kyushu Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Advpharma Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Advpharma Inc

    • Figure Sales and Growth Rate Analysis of Advpharma Inc

    • Figure Revenue and Market Share Analysis of Advpharma Inc

    • Table Product and Service Introduction of Advpharma Inc

    • Table Company Profile and Development Status of Quest Diagnostics Austrian Institute of Technology GmbH

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Quest Diagnostics Austrian Institute of Technology GmbH

    • Figure Sales and Growth Rate Analysis of Quest Diagnostics Austrian Institute of Technology GmbH

    • Figure Revenue and Market Share Analysis of Quest Diagnostics Austrian Institute of Technology GmbH

    • Table Product and Service Introduction of Quest Diagnostics Austrian Institute of Technology GmbH

    • Table Company Profile and Development Status of Agilent

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Agilent

    • Figure Sales and Growth Rate Analysis of Agilent

    • Figure Revenue and Market Share Analysis of Agilent

    • Table Product and Service Introduction of Agilent

    • Table Company Profile and Development Status of Mayo Clinic LLC

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mayo Clinic LLC

    • Figure Sales and Growth Rate Analysis of Mayo Clinic LLC

    • Figure Revenue and Market Share Analysis of Mayo Clinic LLC

    • Table Product and Service Introduction of Mayo Clinic LLC

    • Table Company Profile and Development Status of Emory University

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Emory University

    • Figure Sales and Growth Rate Analysis of Emory University

    • Figure Revenue and Market Share Analysis of Emory University

    • Table Product and Service Introduction of Emory University

    • Table Company Profile and Development Status of Biodesix

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biodesix

    • Figure Sales and Growth Rate Analysis of Biodesix

    • Figure Revenue and Market Share Analysis of Biodesix

    • Table Product and Service Introduction of Biodesix

    • Table Company Profile and Development Status of HalioDx

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of HalioDx

    • Figure Sales and Growth Rate Analysis of HalioDx

    • Figure Revenue and Market Share Analysis of HalioDx

    • Table Product and Service Introduction of HalioDx

    • Table Company Profile and Development Status of Courtagen Life Sciences Inc SAS

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Courtagen Life Sciences Inc SAS

    • Figure Sales and Growth Rate Analysis of Courtagen Life Sciences Inc SAS

    • Figure Revenue and Market Share Analysis of Courtagen Life Sciences Inc SAS

    • Table Product and Service Introduction of Courtagen Life Sciences Inc SAS

    • Table Company Profile and Development Status of Epigenomics AG US

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Epigenomics AG US

    • Figure Sales and Growth Rate Analysis of Epigenomics AG US

    • Figure Revenue and Market Share Analysis of Epigenomics AG US

    • Table Product and Service Introduction of Epigenomics AG US

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US